pharmaceutical preparations and substances for use in the treatment of the central nervous system; pharmaceutical preparations and substances for use in the treatment of schizophrenia; pharmaceutical preparations and substances for use in the treatment of circadian rhythm diseases and disorders; pharmaceutical preparations containing iloperidone; and pharmaceutical preparations containing tasimelteon